مكتبة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Potential value of immunogenic cell death related-genes in refining European leukemiaNet guidelines classification and predicting the immune infiltration landscape in acute myeloid leukemia.

Authors : Jiao, Changqing^1,2 (AUTHOR); Ma, Xiaoyu^1,2 (AUTHOR); Cui, Jianling^1,2 (AUTHOR)

Source: Cancer Cell International. 2/18/2025, Vol. 25 Issue 1, p1-20. 20p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

ARTN and CCL23 predicted chemosensitivity in acute myeloid leukemia: an Olink® proteomics approach.

Authors : Wu, Ting-Shuan^1,2 (AUTHOR); Hsiao, Tzu-Hung^3,4,5,6 (AUTHOR); Chen, Chung-Hsing⁷ (AUTHOR)

Source: Clinical Proteomics. 1/21/2025, Vol. 22 Issue 1, p1-9. 9p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

CAR-macrophages targets CD26 to eliminate chronic myeloid leukemia stem cells.

Authors : Guoyun, Jiang¹ (AUTHOR) ; Yuefeng, Qin¹ (AUTHOR) ; Zhenglan, Huang¹ (AUTHOR)

Source: Experimental Hematology & Oncology. 2/13/2025, Vol. 14 Issue 1, p1-13. 13p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Overexpression and oncogenic role of RIPK3 in acute myeloid leukemia associated with specific subtypes and treatment outcome.

Authors : Wang, Yun^1,2,3,4 (AUTHOR); Zhang, Ting-Juan^1,2,3,4 (AUTHOR); Zhang, Liu-Chao⁵ (AUTHOR)

Source: BMC Cancer. 2/13/2025, Vol. 25 Issue 1, p1-13. 13p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Development and alpha-testing of a patient decision aid for patients with chronic myeloid leukemia regarding dose reduction.

Authors : Lokhorst, D. N.¹ (AUTHOR); Djodikromo, M. F.¹ (AUTHOR); Hermens, R. P. M. G.² (AUTHOR)

Source: BMC Medical Informatics & Decision Making. 12/20/2024, Vol. 24 Issue 1, p1-9. 9p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Chiglitazar diminishes the warburg effect through PPARγ/mTOR/PKM2 and increases the sensitivity of imatinib in chronic myeloid leukemia.

Authors : Duan, Hongpeng^1,2 (AUTHOR) ; Lai, Qian^1,2 (AUTHOR) ; Jiang, Yuelong^1,2 (AUTHOR)

Source: Experimental Hematology & Oncology. 12/18/2024, Vol. 13 Issue 1, p1-19. 19p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Proteomic and metabolomic exploration in relapse acute myeloid leukemia bone marrow supernatant combined with genetic characteristics.

Authors : Ji, Xinyao^1,2,3 (AUTHOR); Yang, Cheng⁴ (AUTHOR) ; Niu, Changchun^1,2 (AUTHOR)

Source: BMC Cancer. 12/18/2024, Vol. 24 Issue 1, p1-11. 11p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis.

Authors : Urrutia, Samuel¹ (AUTHOR); Kantarjian, Hagop M.² (AUTHOR); Ravandi-Kashani, Farhad² (AUTHOR)

Source: Journal of Hematology & Oncology. 11/15/2024, Vol. 17 Issue 1, p1-7. 7p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

TET2 mutation in acute myeloid leukemia: biology, clinical significance, and therapeutic insights.

Authors : Gao, Qiang^1,2 (AUTHOR); Shen, Kefeng^1,2 (AUTHOR) ; Xiao, Min^1,2 (AUTHOR)

Source: Clinical Epigenetics. 11/9/2024, Vol. 16 Issue 1, p1-13. 13p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Dissecting L-glutamine metabolism in acute myeloid leukemia: single-cell insights and therapeutic implications.

Authors : Chen, Yanli¹ (AUTHOR)

Source: Journal of Translational Medicine. 11/6/2024, Vol. 22 Issue 1, p1-15. 15p.

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Potential value of immunogenic cell death related-genes in refining European leukemiaNet guidelines classification and predicting the immune infiltration landscape in acute myeloid leukemia.

ARTN and CCL23 predicted chemosensitivity in acute myeloid leukemia: an Olink® proteomics approach.

CAR-macrophages targets CD26 to eliminate chronic myeloid leukemia stem cells.

Overexpression and oncogenic role of RIPK3 in acute myeloid leukemia associated with specific subtypes and treatment outcome.

Development and alpha-testing of a patient decision aid for patients with chronic myeloid leukemia regarding dose reduction.

Chiglitazar diminishes the warburg effect through PPARγ/mTOR/PKM2 and increases the sensitivity of imatinib in chronic myeloid leukemia.

Proteomic and metabolomic exploration in relapse acute myeloid leukemia bone marrow supernatant combined with genetic characteristics.

Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis.

TET2 mutation in acute myeloid leukemia: biology, clinical significance, and therapeutic insights.

Dissecting L-glutamine metabolism in acute myeloid leukemia: single-cell insights and therapeutic implications.

اتصل بنا

اتبع